ORKA – oruka therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress [Yahoo! Finance]
Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress
Oruka Therapeutics, Inc. (NASDAQ: ORKA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $44.00 price target on the stock.
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $41.00 price target on the stock.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.